Skip to content

Effect of topical atorvastatin in seborrheic dermatitis

Comparative Effectiveness of Atorvastatin 5% lotion vs betamethasone lotion in treatment of seborrheic dermatitis in adult: Double blind Randomized Clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017070922965N11
Enrollment
70
Registered
2017-07-18
Start date
2017-08-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic dermatitis. Other seborrhoeic dermatitis

Interventions

Intervention 1: Intervention group: ketoconazole shampoo three times a week with 5% atorvastatin lotion daily. Intervention 2: Control group: ketoconazole shampoo 3 times a week with betamethasone lot
Treatment - Drugs
Intervention group: ketoconazole shampoo three times a week with 5% atorvastatin lotion daily
Control group: ketoconazole shampoo 3 times a week with betamethasone lotion daily

Sponsors

vice chancellor for research,Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:Patients with seborrheic dermatitis in the scalp and face with clinical diagnosis?Lack of treatment with topical or systemic corticosteroids?Methyl dopa? Chlorpromazine?Topical or systemic acne medications from a month before referral?Failure to develop a systemic disorder, such as Parkinson's disease, AIDS, mood disorders. exclusion criteria:Report any allergy to the drug, such as Contact dermatitis?Dissatisfaction with drug use and collaborative study?Lack of referral for follow up and observation of the therapeutic efficacy of the drug?Having a very severe type of disease(Itching score greater than 7)?Pregnancy and lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Seborrheic dermatitis. Timepoint: 2 and 4 weeks following of treatment and4 weeks after the end of treatment. Method of measurement: Koca scoring system.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mehrpooya

School of Pharmacy,Hamadan University of Medical Sciences

m-mehrpooya2003@yahoo.com+98 81383811594

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026